Xiankuo Yu
Chengdu, 611137, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Large-Scale Transcriptome Profiling and Network Pharmacology Analysis Reveal the Multi-Target Inhibitory Mechanism of Modified Guizhi Fuling Decoction in Prostate Cancer Cells.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 08, 2025
Gene Signature-Based Drug Screening Reveals Ponatinib Enhances Immunotherapy Efficacy in Triple-Negative Breast Cancer by Reversing MDSC-Mediated Immunosuppressive Tumor Microenvironment.
Journal: Research (Washington, D.C.)
Published: May 22, 2025
Gene signature-guided isolation identifies cucurbitacins as STAT3 inhibitors from Picria fel-terrae Lour.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 08, 2024
Oxyresveratrol as a novel ferroptosis inducer exhibits anticancer activity against breast cancer via the EGFR/PI3K/AKT/GPX4 signalling axis.
Journal: Frontiers in pharmacology
Published: November 13, 2024
Identification of chemical inhibitors targeting long noncoding RNA through gene signature-based high throughput screening.
Journal: International journal of biological macromolecules
Published: October 30, 2024
High-throughput profiling of chemical-induced gene expression across 93,644 perturbations.
Journal: Nature methods
Published: July 23, 2024
Comprehensive pan-cancer analysis unveils the significant prognostic value and potential role in immune microenvironment modulation of TRIB3.
Journal: Computational and structural biotechnology journal
Published: July 09, 2023
Ethyl acetate extract of Antenoron Filiforme inhibits the proliferation of triple negative breast cancer cells via suppressing Skp2/p21 signaling axis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: January 16, 2023
A large-scale transcriptional analysis reveals herb-derived ginsenoside F2 suppressing hepatocellular carcinoma via inhibiting STAT3.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 24, 2022
Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS2 technology.
Journal: Journal of ethnopharmacology
Published: October 01, 2022
High-Throughput Strategies for the Discovery of Anticancer Drugs by Targeting Transcriptional Reprogramming.
Journal: Frontiers in oncology
Published: August 20, 2021
Guizhi Fuling Decoction inhibiting the PI3K and MAPK pathways in breast cancer cells revealed by HTS2 technology and systems pharmacology.
Journal: Computational and structural biotechnology journal
Published: February 23, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026